GB Sciences Buy Hold or Sell Recommendation

GBLX -- USA Stock  

USD 0.12  0.0001  0.08%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding GB Sciences is 'Strong Sell'. Macroaxis provides GB Sciences buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding GBLX positions. The advice algorithm takes into account all of GB Sciences available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from GBLX buy-and-hold prospective. Please also check GB Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell GB SciencesBuy GB Sciences
Strong Sell


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Not Available
For the selected time horizon GB Sciences has a mean deviation of 3.58, semi deviation of 0.0, standard deviation of 4.9, variance of 24.01, downside variance of 0.0 and semi variance of 0.0
We provide buy or sell recommendation to complement the latest expert consensus on GB Sciences. Our dynamic recommendation engine utilizes multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at this moment. To make sure GB Sciences is not overpriced, please check out all GB Sciences fundamentals including its Shares Owned by Institutions and the relationship between EBITDA and Total Asset . As GB Sciences appears to be a penny stock we also urge to confirm its Price to Earning numbers.

GB Sciences Trading Alerts and Improvement Suggestions

GB Sciences generates negative expected return over the last 30 days
GB Sciences has high historical volatility and very poor performance
GB Sciences has some characteristics of a very speculative penny stock
GB Sciences has high likelihood to experience some financial distress in the next 2 years
The company currently holds 7.73M in liabilities with Debt to Equity (D/E) ratio of 39.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. GB Sciences has Current Ratio of 0.91 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.
The entity reported previous year revenue of 3.6M. Net Loss for the year was (28.45M) with profit before overhead, payroll, taxes, and interest of 1.73M.
GROWBLOX SCIENCES currently holds about 324.06K in cash with (11.76M) of positive cash flow from operations.

GB Sciences Returns Distribution Density

Mean Return0.67Value At Risk7.17
Potential Upside8.33Standard Deviation4.90
 Return Density 

GB Sciences Greeks

Alpha over DOW
Beta against DOW=0.36
Overall volatility
Information ratio =0.17

GB Sciences Volatility Alert

GB Sciences exhibits very low volatility with skewness of 0.67 and kurtosis of 0.45. However, we advise investors to further study GB Sciences technical indicators to make sure all market info is available and is reliable. GB Sciences is a potential penny stock. Although GB Sciences may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial stock hype. Please make sure you totally understand upside potential and downside risk of investing in GB Sciences. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings,sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
 Better Than Average     
 Worse Than Average Compare GB Sciences to competition

GB Sciences Fundamental Vs Peers

FundamentalsGB SciencesPeer Average
Return On Equity(210.65)% (0.31)%
Return On Asset(44.12)% (0.14)%
Operating Margin(460.61)% (5.51)%
Current Valuation47.14M16.62B
Shares Outstanding228.07M571.82M
Shares Owned by Insiders10.40% 10.09%
Shares Owned by Institutions0.01% 39.21%
Price to Earning(2.08)X28.72X
Price to Book2.71X9.51X
Price to Sales7.99X11.42X
Gross Profit1.73M27.38B
Net Income(28.45M)570.98M
Cash and Equivalents324.06K2.7B
Total Debt7.73M5.32B
Debt to Equity39.90% 48.70%
Current Ratio0.93X2.16X
Book Value Per Share0.05X1.93K
Cash Flow from Operations(11.76M)971.22M
Earnings Per Share(0.15)X3.12X
Number of Employees6018.84K
Market Capitalization28.78M19.03B
Total Asset9.32M29.47B
Retained Earnings(12.82M)9.33B
Working Capital881K1.48B
Current Asset2.2M9.34B
Current Liabilities1.32M7.9B
Z Score-2.98.72